Biogen | BIIB - Trade Creditors


Biogen reported $408.4M in Trade Creditors for its fiscal quarter ending in June of 2025.




Trade Creditors Change Date
AbbVie USD 2.94B 2.66B Dec/2024
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
ALKERMES USD 99.21M 39.37M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Bayer EUR 6.04B 549M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical USD 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Merck USD 4.04B 261M Jun/2025
Moderna USD 175M 51M Jun/2025
Neurocrine Biosciences USD 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sanofi EUR 7.08B 14.54B Jun/2025
Sanofi EUR 7.08B 476M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Teva Pharmaceutical Industries USD 2.5B 208M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
United Therapeutics USD 432M 426M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025